Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Mise à jour : Il y a 4 ans
Référence : NCT00526669

Femme et Homme

Extrait

The study will determine if changes in expression of markers involved in the 5-FU pathways are associated with response to treatment with the combination of lapatinib and capecitabine independent of tumor erbB2 status.


Critère d'inclusion

  • Neoplasms, Gastrointestinal Tract


Liens